Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

B Abrahamsen, T Masud, A Avenell, F Anderson, H E Meyer, C Cooper, H Smith, A Z LaCroix, Hutchison F, D Torgerson, A Johansen, R Jackson, L Rejnmark, J Wactawski-Wende, K Brixen, L Mosekilde, J A Robbins, R M Francis, The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group

Research output: Contribution to journalArticle

261 Citations (Scopus)
3 Downloads (Pure)

Abstract

Objectives To identify participants' characteristics that influence the anti-fracture efficacy of vitamin D or vitamin D plus calcium with respect to any fracture, hip fracture, and clinical vertebral fracture and to assess the influence of dosing regimens and co-administration of calcium.

Design Individual patient data analysis using pooled data from randomised trials.

Data sources Seven major randomised trials of vitamin D with calcium or vitamin D alone, yielding a total of 68 517 participants (mean age 69.9 years, range 47-107 years, 14.7% men).

Study selection Studies included were randomised studies with at least one intervention arm in which vitamin D was given, fracture as an outcome, and at least 1000 participants.

Data synthesis Logistic regression analysis was used to identify significant interaction terms, followed by Cox's proportional hazards models incorporating age, sex, fracture history, and hormone therapy and bisphosphonate use.

Results Trials using vitamin D with calcium showed a reduced overall risk of fracture (hazard ratio 0.92, 95% confidence interval 0.86 to 0.99, P=0.025) and hip fracture (all studies: 0.84, 0.70 to 1.01, P=0.07; studies using 10 mu g of vitamin D given with calcium: 0.74, 0.60 to 0.91, P=0.005). For vitamin D alone in daily doses of 10 mu g or 20 mu g, no significant effects were found. No interaction was found between fracture history and treatment response, nor any interaction with age, sex, or hormone replacement therapy.

Conclusion This individual patient data analysis indicates that vitamin D given alone in doses of 10-20 mu g is not effective in preventing fractures. By contrast, calcium and vitamin D given together reduce hip fractures and total fractures, and probably vertebral fractures, irrespective of age, sex, or previous fractures.

Original languageEnglish
Article numberb5463
Number of pages8
JournalBritish Medical Journal
Volume340
Issue number-
DOIs
Publication statusPublished - 12 Jan 2010

Keywords

  • randomized-controlled-trials
  • placebo-controlled trial
  • D supplementation
  • double-blind
  • osteoporotic fractures
  • elderly-people
  • hip fracture
  • older-people
  • D deficiency
  • bone loss

Cite this

Abrahamsen, B., Masud, T., Avenell, A., Anderson, F., Meyer, H. E., Cooper, C., ... The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group (2010). Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. British Medical Journal, 340(-), [b5463]. https://doi.org/10.1136/bmj.b5463

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. / Abrahamsen, B; Masud, T; Avenell, A; Anderson, F; Meyer, H E; Cooper, C; Smith, H; LaCroix, A Z; F, Hutchison; Torgerson, D; Johansen, A ; Jackson, R; Rejnmark, L; Wactawski-Wende, J; Brixen, K; Mosekilde, L; Robbins, J A; Francis, R M; The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group.

In: British Medical Journal, Vol. 340, No. -, b5463, 12.01.2010.

Research output: Contribution to journalArticle

Abrahamsen, B, Masud, T, Avenell, A, Anderson, F, Meyer, HE, Cooper, C, Smith, H, LaCroix, AZ, F, H, Torgerson, D, Johansen, A, Jackson, R, Rejnmark, L, Wactawski-Wende, J, Brixen, K, Mosekilde, L, Robbins, JA, Francis, RM & The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group 2010, 'Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe' British Medical Journal, vol. 340, no. -, b5463. https://doi.org/10.1136/bmj.b5463
Abrahamsen, B ; Masud, T ; Avenell, A ; Anderson, F ; Meyer, H E ; Cooper, C ; Smith, H ; LaCroix, A Z ; F, Hutchison ; Torgerson, D ; Johansen, A ; Jackson, R ; Rejnmark, L ; Wactawski-Wende, J ; Brixen, K ; Mosekilde, L ; Robbins, J A ; Francis, R M ; The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group. / Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. In: British Medical Journal. 2010 ; Vol. 340, No. -.
@article{f990befdf914445ca0a57822ec4fdddf,
title = "Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe",
abstract = "Objectives To identify participants' characteristics that influence the anti-fracture efficacy of vitamin D or vitamin D plus calcium with respect to any fracture, hip fracture, and clinical vertebral fracture and to assess the influence of dosing regimens and co-administration of calcium.Design Individual patient data analysis using pooled data from randomised trials.Data sources Seven major randomised trials of vitamin D with calcium or vitamin D alone, yielding a total of 68 517 participants (mean age 69.9 years, range 47-107 years, 14.7{\%} men).Study selection Studies included were randomised studies with at least one intervention arm in which vitamin D was given, fracture as an outcome, and at least 1000 participants.Data synthesis Logistic regression analysis was used to identify significant interaction terms, followed by Cox's proportional hazards models incorporating age, sex, fracture history, and hormone therapy and bisphosphonate use.Results Trials using vitamin D with calcium showed a reduced overall risk of fracture (hazard ratio 0.92, 95{\%} confidence interval 0.86 to 0.99, P=0.025) and hip fracture (all studies: 0.84, 0.70 to 1.01, P=0.07; studies using 10 mu g of vitamin D given with calcium: 0.74, 0.60 to 0.91, P=0.005). For vitamin D alone in daily doses of 10 mu g or 20 mu g, no significant effects were found. No interaction was found between fracture history and treatment response, nor any interaction with age, sex, or hormone replacement therapy.Conclusion This individual patient data analysis indicates that vitamin D given alone in doses of 10-20 mu g is not effective in preventing fractures. By contrast, calcium and vitamin D given together reduce hip fractures and total fractures, and probably vertebral fractures, irrespective of age, sex, or previous fractures.",
keywords = "randomized-controlled-trials, placebo-controlled trial, D supplementation, double-blind, osteoporotic fractures, elderly-people, hip fracture, older-people, D deficiency, bone loss",
author = "B Abrahamsen and T Masud and A Avenell and F Anderson and Meyer, {H E} and C Cooper and H Smith and LaCroix, {A Z} and Hutchison F and D Torgerson and A Johansen and R Jackson and L Rejnmark and J Wactawski-Wende and K Brixen and L Mosekilde and Robbins, {J A} and Francis, {R M} and {The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group}",
year = "2010",
month = "1",
day = "12",
doi = "10.1136/bmj.b5463",
language = "English",
volume = "340",
journal = "BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "-",

}

TY - JOUR

T1 - Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

AU - Abrahamsen, B

AU - Masud, T

AU - Avenell, A

AU - Anderson, F

AU - Meyer, H E

AU - Cooper, C

AU - Smith, H

AU - LaCroix, A Z

AU - F, Hutchison

AU - Torgerson, D

AU - Johansen, A

AU - Jackson, R

AU - Rejnmark, L

AU - Wactawski-Wende, J

AU - Brixen, K

AU - Mosekilde, L

AU - Robbins, J A

AU - Francis, R M

AU - The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group

PY - 2010/1/12

Y1 - 2010/1/12

N2 - Objectives To identify participants' characteristics that influence the anti-fracture efficacy of vitamin D or vitamin D plus calcium with respect to any fracture, hip fracture, and clinical vertebral fracture and to assess the influence of dosing regimens and co-administration of calcium.Design Individual patient data analysis using pooled data from randomised trials.Data sources Seven major randomised trials of vitamin D with calcium or vitamin D alone, yielding a total of 68 517 participants (mean age 69.9 years, range 47-107 years, 14.7% men).Study selection Studies included were randomised studies with at least one intervention arm in which vitamin D was given, fracture as an outcome, and at least 1000 participants.Data synthesis Logistic regression analysis was used to identify significant interaction terms, followed by Cox's proportional hazards models incorporating age, sex, fracture history, and hormone therapy and bisphosphonate use.Results Trials using vitamin D with calcium showed a reduced overall risk of fracture (hazard ratio 0.92, 95% confidence interval 0.86 to 0.99, P=0.025) and hip fracture (all studies: 0.84, 0.70 to 1.01, P=0.07; studies using 10 mu g of vitamin D given with calcium: 0.74, 0.60 to 0.91, P=0.005). For vitamin D alone in daily doses of 10 mu g or 20 mu g, no significant effects were found. No interaction was found between fracture history and treatment response, nor any interaction with age, sex, or hormone replacement therapy.Conclusion This individual patient data analysis indicates that vitamin D given alone in doses of 10-20 mu g is not effective in preventing fractures. By contrast, calcium and vitamin D given together reduce hip fractures and total fractures, and probably vertebral fractures, irrespective of age, sex, or previous fractures.

AB - Objectives To identify participants' characteristics that influence the anti-fracture efficacy of vitamin D or vitamin D plus calcium with respect to any fracture, hip fracture, and clinical vertebral fracture and to assess the influence of dosing regimens and co-administration of calcium.Design Individual patient data analysis using pooled data from randomised trials.Data sources Seven major randomised trials of vitamin D with calcium or vitamin D alone, yielding a total of 68 517 participants (mean age 69.9 years, range 47-107 years, 14.7% men).Study selection Studies included were randomised studies with at least one intervention arm in which vitamin D was given, fracture as an outcome, and at least 1000 participants.Data synthesis Logistic regression analysis was used to identify significant interaction terms, followed by Cox's proportional hazards models incorporating age, sex, fracture history, and hormone therapy and bisphosphonate use.Results Trials using vitamin D with calcium showed a reduced overall risk of fracture (hazard ratio 0.92, 95% confidence interval 0.86 to 0.99, P=0.025) and hip fracture (all studies: 0.84, 0.70 to 1.01, P=0.07; studies using 10 mu g of vitamin D given with calcium: 0.74, 0.60 to 0.91, P=0.005). For vitamin D alone in daily doses of 10 mu g or 20 mu g, no significant effects were found. No interaction was found between fracture history and treatment response, nor any interaction with age, sex, or hormone replacement therapy.Conclusion This individual patient data analysis indicates that vitamin D given alone in doses of 10-20 mu g is not effective in preventing fractures. By contrast, calcium and vitamin D given together reduce hip fractures and total fractures, and probably vertebral fractures, irrespective of age, sex, or previous fractures.

KW - randomized-controlled-trials

KW - placebo-controlled trial

KW - D supplementation

KW - double-blind

KW - osteoporotic fractures

KW - elderly-people

KW - hip fracture

KW - older-people

KW - D deficiency

KW - bone loss

U2 - 10.1136/bmj.b5463

DO - 10.1136/bmj.b5463

M3 - Article

VL - 340

JO - BMJ

JF - BMJ

SN - 0959-8146

IS - -

M1 - b5463

ER -